Your browser doesn't support javascript.
loading
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.
Silverberg, Jonathan I; Simpson, Eric L; Thyssen, Jacob Pontoppidan; Werfel, Thomas; Cardillo, Tracy E; Colvin, Stephanie; Pierce, Evangeline; Chen, Yun-Fei; Chen, Sherry; Eichenfield, Lawrence.
Afiliação
  • Silverberg JI; Department of Dermatology, George Washington University School of Medicine, Washington, District of Columbia, USA.
  • Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
  • Thyssen JP; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Werfel T; Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Cardillo TE; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Colvin S; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Pierce E; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Chen YF; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Chen S; Tigermed, Somerset, New Jersey, USA.
  • Eichenfield L; Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine and Rady Children's Hospital, San Diego, California, USA.
J Eur Acad Dermatol Venereol ; 37(5): 1036-1045, 2023 May.
Article em En | MEDLINE | ID: mdl-36514996

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Fármacos Dermatológicos Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Fármacos Dermatológicos Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article